Evidence map›Paper›PMID 21921034›Full record

ArticleThe Journal of biological chemistry2011

Disruption of serine/threonine protein phosphatase 5 (PP5:PPP5c) in mice reveals a novel role for PP5 in the regulation of ultraviolet light-induced phosphorylation of serine/threonine protein kinase Chk1 (CHEK1).

Lauren Amable, Nina Grankvist, Jason W Largen, Henrik Ortsäter, Åke Sjöholm, Richard E Honkanen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Plk4 Is a Novel Substrate of Protein Phosphatase 5.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Cuminal InhibitsMicroorganisms · 2020
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genetic analysis of litter size in mice.The Journal of veterinary medical science · 2015
    Article
  18. Protein phosphatases in pancreatic islets.The Journal of endocrinology · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Lauren AmableDepartment of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, Alabama 36688, USA.
Nina Grankvist
Jason W Largen
Henrik Ortsäter
Åke Sjöholm
Richard E Honkanen
Stockholm South General Hospital · SEUniversity of South Alabama · USKarolinska Institutet · SEKarolinska University Hospital · SE

Funding

Training in Cell Signaling and Lung PathobiologyT32HL076125 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI RICH, THOMAS C, STEVENS, TROY · 2004 to 2018
$2.7M
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESISR01CA060750 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI HONKANEN, RICHARD E · 1999 to 2009
$2.5M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR011174 · NCRR · UNIVERSITY OF SOUTH ALABAMA · PI ABEE, CHRISTIAN R · 1995 to 1995
–
MECHANISMS OF TUMOR PROMOTION AND CARCINOGENESISR29CA060750 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI HONKANEN, RICHARD E · 1994 to 1998
–
NCI NIH HHS CA60750NCI NIH HHS R01 CA060750NCRR NIH HHS C06 RR11174NHLBI NIH HHS T32 HL076125
6 · The paper itself

Abstract

PP5 is a ubiquitously expressed Ser/Thr protein phosphatase. High levels of PP5 have been observed in human cancers, and constitutive PP5 overexpression aids tumor progression in mouse models of tumor development. However, PP5 is highly conserved among species, and the roles of PP5 in normal tissues are not clear. Here, to help evaluate the biological actions of PP5, a Cre/loxP-conditional mouse line was generated. In marked contrast to the early embryonic lethality associated with the genetic disruption of other PPP family phosphatases (e.g. PP2A and PP4), intercrosses with mouse lines that ubiquitously express Cre recombinase starting early in development (e.g. MeuCre40 and ACTB-Cre) produced viable and fertile PP5-deficient mice. Phenotypic differences caused by the total disruption of PP5 were minor, suggesting that small molecule inhibitors of PP5 will not have widespread systemic toxicity. Examination of roles for PP5 in fibroblasts generated from PP5-deficient embryos (PP5(-/-) mouse embryonic fibroblasts) confirmed some known roles and identified new actions for PP5. PP5(-/-) mouse embryonic fibroblasts demonstrated increased sensitivity to UV light, hydroxyurea, and camptothecin, which are known activators of ATR (ataxia-telangiectasia and Rad3-related) kinase. Further study revealed a previously unrecognized role for PP5 downstream of ATR activation in a UV light-induced response. The genetic disruption of PP5 is associated with enhanced and prolonged phosphorylation of a single serine (Ser-345) on Chk1, increased phosphorylation of the p53 tumor suppressor protein (p53) at serine 18, and increased p53 protein levels. A comparable role for PP5 in the regulation of Chk1 phosphorylation was also observed in human cells.

Indexed as

Ultraviolet RaysActinsAllelesAnimalsBlastocystBreedingcdc25 PhosphatasesCell LineCheckpoint Kinase 1FemaleFibroblastsHeLa CellsHumansHydroxyureaIntegrasesMaleActinsCdc25a protein, mousecdc25 PhosphatasesCheckpoint Kinase 1CHEK1 protein, humanChek1 protein, mouseCre recombinaseHydroxyureaIntegrasesneuropeptide Y4 receptorNuclear ProteinsPhosphoprotein PhosphatasesProtein Kinasesprotein phosphatase 5Receptors, Neuropeptide YSerineTumor Suppressor Protein p53

Identifiers

PMID21921034
PMCPMC3220460
OpenAlexW2033250269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.